Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bridging the gap: metabolic and endocrine care of patients during transition.
Hokken-Koelega A, van der Lely AJ, Hauffa B, Häusler G, Johannsson G, Maghnie M, Argente J, DeSchepper J, Gleeson H, Gregory JW, Höybye C, Keleştimur F, Luger A, Müller HL, Neggers S, Popovic-Brkic V, Porcu E, Sävendahl L, Shalet S, Spiliotis B, Tauber M. Hokken-Koelega A, et al. Among authors: savendahl l. Endocr Connect. 2016 Nov;5(6):R44-R54. doi: 10.1530/EC-16-0028. Epub 2016 Nov 1. Endocr Connect. 2016. PMID: 27803155 Free PMC article. Review.
The crosstalk between FGF21 and GH leads to weakened GH receptor signaling and IGF1 expression and is associated with growth failure in very preterm infants.
Mistry JN, Silvennoinen S, Zaman F, Sävendahl L, Mariniello K, Hall C, Howard SR, Dunkel L, Sankilampi U, Guasti L. Mistry JN, et al. Among authors: savendahl l. Front Endocrinol (Lausanne). 2023 May 12;14:1105602. doi: 10.3389/fendo.2023.1105602. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37251684 Free PMC article.
Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.
Sävendahl L, Maes M, Albertsson-Wikland K, Borgström B, Carel JC, Henrard S, Speybroeck N, Thomas M, Zandwijken G, Hokken-Koelega A. Sävendahl L, et al. J Clin Endocrinol Metab. 2012 Feb;97(2):E213-7. doi: 10.1210/jc.2011-2882. Epub 2012 Jan 11. J Clin Endocrinol Metab. 2012. PMID: 22238393
The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®).
Höybye C, Sävendahl L, Christesen HT, Lee P, Pedersen BT, Schlumpf M, Germak J, Ross J. Höybye C, et al. Among authors: savendahl l. Clin Epidemiol. 2013 Apr 26;5:119-27. doi: 10.2147/CLEP.S42602. Print 2013. Clin Epidemiol. 2013. PMID: 23658497 Free PMC article.
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
Boguszewski MCS, Boguszewski CL, Chemaitilly W, Cohen LE, Gebauer J, Higham C, Hoffman AR, Polak M, Yuen KCJ, Alos N, Antal Z, Bidlingmaier M, Biller BMK, Brabant G, Choong CSY, Cianfarani S, Clayton PE, Coutant R, Cardoso-Demartini AA, Fernandez A, Grimberg A, Guðmundsson K, Guevara-Aguirre J, Ho KKY, Horikawa R, Isidori AM, Jørgensen JOL, Kamenicky P, Karavitaki N, Kopchick JJ, Lodish M, Luo X, McCormack AI, Meacham L, Melmed S, Mostoufi Moab S, Müller HL, Neggers SJCMM, Aguiar Oliveira MH, Ozono K, Pennisi PA, Popovic V, Radovick S, Savendahl L, Touraine P, van Santen HM, Johannsson G. Boguszewski MCS, et al. Among authors: savendahl l. Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52. doi: 10.1530/EJE-21-1186. Eur J Endocrinol. 2022. PMID: 35319491 Free PMC article. Review.
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.
Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, Butler G, Chihara K, Christiansen J, Cianfarani S, Clayton P, Clemmons D, Cohen P, Darendeliler F, Deal C, Dunger D, Erfurth EM, Fuqua JS, Grimberg A, Haymond M, Higham C, Ho K, Hoffman AR, Hokken-Koelega A, Johannsson G, Juul A, Kopchick J, Lee P, Pollak M, Radovick S, Robison L, Rosenfeld R, Ross RJ, Savendahl L, Saenger P, Sorensen HT, Stochholm K, Strasburger C, Swerdlow A, Thorner M. Allen DB, et al. Among authors: savendahl l. Eur J Endocrinol. 2016 Feb;174(2):P1-9. doi: 10.1530/EJE-15-0873. Epub 2015 Nov 12. Eur J Endocrinol. 2016. PMID: 26563978 Free PMC article.
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.
Swerdlow AJ, Cooke R, Beckers D, Borgström B, Butler G, Carel JC, Cianfarani S, Clayton P, Coste J, Deodati A, Ecosse E, Gausche R, Giacomozzi C, Hokken-Koelega ACS, Khan AJ, Kiess W, Kuehni CE, Mullis PE, Pfaffle R, Sävendahl L, Sommer G, Thomas M, Tidblad A, Tollerfield S, Van Eycken L, Zandwijken GRJ. Swerdlow AJ, et al. Among authors: savendahl l. J Clin Endocrinol Metab. 2017 May 1;102(5):1661-1672. doi: 10.1210/jc.2016-2046. J Clin Endocrinol Metab. 2017. PMID: 28187225 Free PMC article.
Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
Swerdlow AJ, Cooke R, Beckers D, Butler G, Carel JC, Cianfarani S, Clayton P, Coste J, Deodati A, Ecosse E, Hokken-Koelega ACS, Khan AJ, Kiess W, Kuehni CE, Flück CE, Pfaffle R, Sävendahl L, Sommer G, Thomas M, Tidblad A, Tollerfield S, Zandwijken GRJ. Swerdlow AJ, et al. Among authors: savendahl l. J Clin Endocrinol Metab. 2019 Mar 1;104(3):658-664. doi: 10.1210/jc.2018-01133. J Clin Endocrinol Metab. 2019. PMID: 30137467 Free PMC article.
Effects of the selective GPER1 agonist G1 on bone growth.
Iravani M, Lagerquist MK, Karimian E, Chagin AS, Ohlsson C, Sävendahl L. Iravani M, et al. Among authors: savendahl l. Endocr Connect. 2019 Sep;8(9):1302-1309. doi: 10.1530/EC-19-0274. Endocr Connect. 2019. PMID: 31434056 Free PMC article.
160 results